Literature DB >> 9530276

Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury.

G P Kaushal1, A B Singh, S V Shah.   

Abstract

In the present study, we demonstrate that rat kidney contains caspase activity that was markedly inhibited by specific peptide inhibitors of caspases but not by inhibitors of Ser, Cys, Asp, or metalloproteinases. Using primers based on the nucleotide sequence of known members of Ced-3/interleukin-1 beta-converting enzyme (ICE) family from human origin, we have identified by reverse-transcription (RT) polymerase chain reaction (PCR) analyses that rat kidney transcribes the genes for caspase-1 (ICE), caspase-2 (Nedd2), caspase-3 (CPP32), and caspase-6 (Mch2). RT-PCR products, when subcloned and sequenced, provided full-length cDNAs for ICE (1,209 bp) and CPP32 (786 bp) and partial cDNA products for Mch2 (561 bp) and Nedd2 (811 bp). The sequence analysis of the caspase cDNAs showed conserved catalytic site QACRG as well as Asp cleavage site. Rat kidneys subjected to ischemia-reperfusion injury revealed differential expression of caspases with marked increase in CPP32 and ICE mRNA and proteins during reperfusion, transient increase in Nedd2 mRNA and proteins during ischemia and the early period of reperfusion, and little change in Mch2 expression during the ischemia or reperfusion period. The altered expression suggests that caspases may act in concert in a cascade and may play an important role in ischemic acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530276     DOI: 10.1152/ajprenal.1998.274.3.F587

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Characterization of cell clones stably transfected with short form caspase-9: apoptotic resistance and Bcl-XL expression.

Authors:  Xiaolan Yi; Jinzhao Wang; Dai-Wu Seol; Zheng Dong
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

3.  Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

Authors:  Charuhas V Thakar; Kamyar Zahedi; Monica P Revelo; Zhaohui Wang; Charles E Burnham; Sharon Barone; Shannon Bevans; Alex B Lentsch; Hamid Rabb; Manoocher Soleimani
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  p53 target Siva regulates apoptosis in ischemic kidneys.

Authors:  Kurinji Singaravelu; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-09

Review 5.  Regulated cell death in AKI.

Authors:  Andreas Linkermann; Guochun Chen; Guie Dong; Ulrich Kunzendorf; Stefan Krautwald; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

6.  cDNA cloning and promoter analysis of rat caspase-9.

Authors:  J Nishiyama; X Yi; M A Venkatachalam; Z Dong
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

Review 7.  Lipid raft redox signaling: molecular mechanisms in health and disease.

Authors:  Si Jin; Fan Zhou; Foad Katirai; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

8.  Leupeptin-based inhibitors do not improve the mdx phenotype.

Authors:  Joshua Selsby; Klara Pendrak; Monica Zadel; Zuozhen Tian; Jennifer Pham; Ted Carver; Pedro Acosta; Elisabeth Barton; H Lee Sweeney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-15       Impact factor: 3.619

9.  Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.

Authors:  Krishna M Boini; Chun Zhang; Min Xia; Wei-Qing Han; Christopher Brimson; Justin L Poklis; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2010-09-19

10.  Okadaic acid stimulates caspase-like activities and induces apoptosis of cultured rat mesangial cells.

Authors:  Narayanan Parameswaran; William S Spielman; David P Brooks; Ponnal Nambi
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.